Agere Pharmaceuticals Overview

  • Founded
  • 2008
  • Status
  • Acquired/​Merged
  • Employees
  • 53
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Agere Pharmaceuticals General Information


Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company specializes in improving the oral bioavailability of BCS II - IV compounds through fundamental science, solubilization expertise, and proprietary solubilization technologies.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 62925 NorthEast 18th Street
  • Bend, OR 97701
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Agere Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Agere Pharmaceuticals‘s full profile, request access.

Request a free trial

Agere Pharmaceuticals Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company speci
Bend, OR
53 As of 2015
000 0000-00-00


onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nul
Boston, MA
000 As of 0000
00000000000 00000


xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 00000000
Cambridge, MA
00 As of 0000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Agere Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ziopharm Oncology Corporation Boston, MA 000 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Agere Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Marshall Crew Ph.D President & Chief Executive Officer
Casey Jones Vice President, Corporate Development
Michael Deperro Vice President, Operations
To view Agere Pharmaceuticals’s complete executive team members history, request access »

Agere Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial